MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
about
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesB Cells and Functional Antibody Responses to Combat InfluenzaA cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults.A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination.Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenExperimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesCombined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule.Re-engaging cross-reactive memory B cells: the influenza puzzle.A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly.Quantitative review of antibody response to inactivated seasonal influenza vaccines.Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.Vaccines against drug abuse.Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.Human influenza vaccines and assessment of immunogenicity.Phytol-derived novel isoprenoid immunostimulants.Adjuvanted influenza vaccines.A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.Controlling influenza by cytotoxic T-cells: calling for help from destroyers.Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009.The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy.Recombinant Vaccines: Development, Production, and Application
P2860
Q21142689-9F586B86-2A9A-405D-9547-18E995765C47Q26801639-E430428B-8C54-4734-9240-C5E1399652E4Q30210342-190B4534-536A-4E33-B3AD-95DB53807763Q30368934-2F2D0F92-0747-416C-BD69-1995B6F14ACEQ30371111-ED43632C-1BF7-4ECA-B48A-542333F2BCAFQ30427591-39A992C9-50A4-4261-9869-11DB09A465E7Q30428833-7742BB3E-4055-49A4-A22F-8DF6D0137B83Q33353517-49DDE053-00B5-4DC6-B197-335C98A1D0FFQ34289880-50190D03-370F-4946-9479-77DFFCA26C65Q35218808-39CB4AC2-78AB-420D-B4F1-9216EDFD9CF9Q35887679-73BEFF97-001B-4359-8BF0-B89FD9EDE38AQ35938624-54965D0D-2E89-44EB-9439-55D7DFEB6EABQ37694883-BAFDB217-7C51-482E-8AB8-9FB0CA5E8E28Q37812125-C5282224-D836-4BDD-919D-912AD503462BQ38008360-4C9E4034-8DE2-427F-9D11-680510638E2CQ38140045-F3BC9142-28F6-4E76-BB44-50002AA9B352Q40691072-E39C0E10-FA41-4F38-B216-14720DE67CD6Q40730765-B287FD95-8FF5-4581-BE9F-06AE683CAA0EQ41905155-619700F8-8CD0-420F-97D0-A240B81D1DB4Q42926219-62692FD7-E4CF-477D-973B-38780B88C532Q46093412-CE596916-3B8A-478C-8033-9A08115B587AQ48145472-E2D3D4CD-7D2E-463F-A8F2-E4DAE60656EDQ56936206-497E4C84-BA7D-4162-9989-2AD476D4A99D
P2860
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@ast
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@en
type
label
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@ast
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@en
prefLabel
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@ast
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@en
P2093
P2860
P921
P1476
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
@en
P2093
Angelika Banzhoff
Audino Podda
Elena Fragapane
Giuseppe Del Giudice
Nicola Groth
P2860
P304
P356
10.1111/J.1750-2659.2008.00059.X
P577
2008-11-01T00:00:00Z